Gemcitabine chemotherapy is used to treat advanced cancers of the breast, ovaries, pancreas, and lungs. It works by disrupting DNA replication, which inhibits a cell’s ability to divide and multiply.

Circulating Tumor DNA and Late Recurrence in High-Risk Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer Clinical trials frequently include multiple end points ...

Please provide your email address to receive an email when new articles are posted on . Intra-arterial administration of gemcitabine conferred a median PFS benefit of 8 months when compared with ...

Immunotherapy improved overall survival when added to cisplatin-gemcitabine but not when added to carboplatin-gemcitabine. Adding immunotherapy to platinum-gemcitabine chemotherapy can improve ...

No new agent has improved overall survival in patients with unresectable or metastatic urothelial carcinoma when added to first-line cisplatin-based chemotherapy. In this phase 3, multinational, ...

Please provide your email address to receive an email when new articles are posted on . Antibiotic receipt in the month before or after gemcitabine treatment improved survival in metastatic pancreatic ...